Unternehmen Quest Diagnostics Incorporated
Aktien
904533
US74834L1008
DGX
Gesundheitspflege Einrichtungen
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
137,6 USD | +0,62 % | +8,32 % | -0,24 % |
24.04. | QUEST DIAGNOSTICS INCORPORATED : Jefferies & Co. gibt eine Kauf-Bewertung ab | ZM |
24.04. | QUEST DIAGNOSTICS INCORPORATED : UBS klebt neutral | ZM |
Kurzporträt
- Tests und diagnostische Dienstleistungen (97,3%): klinische Routinetests, Gentests und fortgeschrittene diagnostische und anatomisch-pathologische Dienstleistungen;
- Sonstige (2,7%).
Mitarbeiterzahl: 50 000
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Diagnostic Information Services
97,0
%
| 9 609 | 97,2 % | 8 976 | 97,0 % | -6,59 % |
All Other
3,0
%
| 274 | 2,8 % | 276 | 3,0 % | +0,73 % |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 9 883 | 100,0 % | 9 252 | 100,0 % | -6,38 % |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
James Davis
CEO | Chief Executive Officer | 61 | 01.04.13 |
Sam Samad
DFI | Director of Finance/CFO | 54 | 11.07.22 |
Kristin Wallace
CMP | Compliance Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 18.02.19 | |
Shawn Bevec
IRC | Investor Relations Contact | - | - |
Sean Mersten
SEC | Corporate Secretary | - | - |
Mark Delaney
PRN | Corporate Officer/Principal | - | 01.03.22 |
Michael Deppe
AUD | Comptroller/Controller/Auditor | 59 | 01.01.98 |
Alyssa Waxenberg
PRN | Corporate Officer/Principal | 53 | 01.01.21 |
Doug Lang
PRN | Corporate Officer/Principal | - | 01.04.13 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Denise Morrison
BRD | Director/Board Member | 70 | 18.02.19 |
Timothy Ring
BRD | Director/Board Member | 66 | 07.12.11 |
Gail Wilensky
BRD | Director/Board Member | 80 | 01.01.97 |
Gary M. Pfeiffer
BRD | Director/Board Member | 74 | 01.12.04 |
Timothy Main
BRD | Director/Board Member | 66 | 13.01.14 |
Vicky Gregg
BRD | Director/Board Member | 69 | 22.07.14 |
Tracey Doi
BRD | Director/Board Member | 63 | 17.08.21 |
Wright Lassiter
BRD | Director/Board Member | 60 | 12.03.20 |
James Davis
CEO | Chief Executive Officer | 61 | 01.04.13 |
Luis A. Diaz
BRD | Director/Board Member | 53 | 17.05.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 162 000 000 | 110 582 365 ( 68,26 %) | 51 000 000 ( 31,48 %) | 68,26 % |
Unternehmenskontakt
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
Blueprint Genetics Oy
Blueprint Genetics Oy BiotechnologyHealth Technology Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland. |
Biotechnology
|
Quest Diagnostics India Pvt Ltd.
Quest Diagnostics India Pvt Ltd. Medical/Nursing ServicesHealth Services Quest Diagnostics India Pvt Ltd. provides pathology and clinical laboratory testing services. It offers employee life cycle approach, pre-employment screening, drug testing solutions, occupational exposure screening and monitoring blueprint for wellness driving healthy behavior & outcomes. The company is headquartered in Gurgaon, India. |
Medical/Nursing Services
|
Quest Diagnostics HTAS India Pvt Ltd.
|
Sektor
Umsatz nach Geschäftsbereich
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-0,24 % | 15,28 Mrd. | |
-14,17 % | 85,42 Mrd. | |
+17,86 % | 84,38 Mrd. | |
+10,92 % | 29,39 Mrd. | |
-8,51 % | 17,49 Mrd. | |
-2,46 % | 16,44 Mrd. | |
-2,48 % | 11,71 Mrd. | |
+0,90 % | 12,22 Mrd. | |
-31,58 % | 11,98 Mrd. | |
+26,71 % | 11,64 Mrd. |
- Börse
- Aktien
- 904533 Aktie
- Unternehmen Quest Diagnostics Incorporated